Stockscreener 앱 받기
45.68
1.36%
-0.63
Anaptysbio Inc 주식(ANAB)의 최신 뉴스
Did Big EPS, Revenue Jump and JPM Spotlight Just Shift AnaptysBio's (ANAB) Investment Narrative? - simplywall.st
ANAPTYSBIO INC (NASDAQ:ANAB) Shows Minervini Trend Template and High-Growth Momentum Alignment - Chartmill
AnaptysBio Shares Face Pressure Amid Insider Sale and Strategic Uncertainty - AD HOC NEWS
Market Leaders: Is AnaptysBio Inc stock a good dividend stock2025 Pullback Review & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Anaptysbio director Marquet sells $530k in shares By Investing.com - Investing.com Nigeria
AnaptysBio (NASDAQ:ANAB) Director Magda Marquet Sells 11,000 Shares - MarketBeat
Anaptysbio director Marquet sells $530k in shares - Investing.com
Breakout Zone: Can AnaptysBio Inc generate free cash flowWeekly Stock Analysis & Real-Time Volume Trigger Notifications - baoquankhu1.vn
AnaptysBio (NASDAQ:ANAB) Stock Price Down 7.3%Time to Sell? - MarketBeat
ANAB Stock Price, Forecast & Analysis | ANAPTYSBIO INC (NASDAQ:ANAB) - Chartmill
AnaptysBio Teases 2026 Split, JEMPERLI Royalty Upside and Key Clinical Catalysts at JPM Conf - MarketBeat
ANAB: Separation into two focused entities targets value creation, with major clinical and royalty catalysts ahead - TradingView — Track All Markets
What This Insider Trim at AnaptysBio Means for Investors After a 260% Stock Rally - AOL.com
AnaptysBio (NASDAQ:ANAB) Stock Price Up 7.2%Time to Buy? - MarketBeat
AnaptysBio stock: UBS reiterates Buy rating amid ongoing GSK litigation By Investing.com - Investing.com Canada
Royalty Pharma and Teva’s $500 million IL-15 deal boosts AnaptysBio stock By Investing.com - Investing.com Nigeria
Royalty Pharma and Teva’s $500 million IL-15 deal boosts AnaptysBio stock - Investing.com Australia
What Investors Should Know About a $163K AnaptysBio Insider Sale - sharewise.com
Why AnaptysBio Inc. stock could rally in 2025GDP Growth & Free Safe Capital Growth Stock Tips - Улправда
Assessing AnaptysBio (ANAB) Valuation After Strong Recent Share Price Momentum - Yahoo Finance
AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty - ET Pharma
Anaptysbio CEO Faga sells $638k in shares By Investing.com - Investing.com South Africa
Anaptysbio CEO Faga sells $638k in shares - Investing.com
Anaptysbio (ANAB) chief medical officer sells $163,191 in stock By Investing.com - Investing.com UK
Anaptysbio CLO Loumeau sells $98,809 in shares By Investing.com - Investing.com Nigeria
Anaptysbio CFO Mulroy sells $112k in shares By Investing.com - Investing.com Canada
AnaptysBio (NASDAQ:ANAB) CFO Dennis Mulroy Sells 2,515 Shares - MarketBeat
Eric Loumeau Sells 2,210 Shares of AnaptysBio (NASDAQ:ANAB) Stock - MarketBeat
AnaptysBio (NASDAQ:ANAB) CEO Daniel Faga Sells 14,281 Shares - MarketBeat
Anaptysbio CLO Loumeau sells $98,809 in shares - Investing.com
The Technical Signals Behind (ANAB) That Institutions Follow - Stock Traders Daily
What AnaptysBio (ANAB)'s Royalty Spin-Off Plan Means For Shareholders - Sahm
AnaptysBio files motion to dismiss in Tesaro/GSK royalty dispute By Investing.com - Investing.com Nigeria
AnaptysBio (NASDAQ:ANAB) Shares Gap Down Following Insider Selling - MarketBeat
Is AnaptysBio Inc. stock positioned for digital transformationGrip and Outsole Review & HOKA model picks for your routine - Улправда
AnaptysBio (NASDAQ:ANAB) Upgraded at UBS Group - MarketBeat
AnaptysBio Moves to Toss GSK/Tesaro Repudiation Claim Over Jemperli Royalties - prismedia.ai
Anaptysbio (ANAB) chief medical officer sells $163,191 in stock - Investing.com
Anaptysbio CFO Mulroy sells $86k in shares By Investing.com - Investing.com Canada
Anaptysbio CFO Mulroy sells $86k in shares - Investing.com India
What dividend safety score for AnaptysBio Inc. stockPortfolio Return Report & AI Optimized Trading Strategy Guides - ulpravda.ru
AnaptysBio CMO Lizzul sells $100k in stock By Investing.com - Investing.com South Africa
Anaptysbio chief legal officer Loumeau sells $439k in stock By Investing.com - Investing.com Canada
Anaptysbio chief legal officer Loumeau sells $439k in stock - Investing.com
4.73%
0.92%
자본화:
|
볼륨(24시간):